A detailed history of Codex Capital, L.L.C. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Codex Capital, L.L.C. holds 11,750 shares of VRTX stock, worth $5.9 Million. This represents 2.39% of its overall portfolio holdings.

Number of Shares
11,750
Previous 11,750 -0.0%
Holding current value
$5.9 Million
Previous $4.78 Billion 2.73%
% of portfolio
2.39%
Previous 2.79%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$338.18 - $362.46 $676,360 - $724,920
2,000 Added 20.51%
11,750 $4.09 Billion
Q2 2023

Jul 31, 2023

BUY
$314.42 - $351.91 $644,561 - $721,415
2,050 Added 26.62%
9,750 $3.43 Billion
Q3 2022

Nov 10, 2022

BUY
$273.83 - $305.53 $2.11 Million - $2.35 Million
7,700 New
7,700 $2.23 Billion

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Codex Capital, L.L.C. Portfolio

Follow Codex Capital, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Codex Capital, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Codex Capital, L.L.C. with notifications on news.